Core C has overall responsible for the organizational structure and progress of this Program Project. Dr Cunningham-Rundles works with each of the Program Leaders, the Administrators and the external Advisory Board (see below) to monitor the progress of each, and help define new directions. The Pis and sub investigators meet monthly face to face, or more often if needed, to discuss ongoing collaborations, share materials, discuss new data and refine techniques. The group reviews also all aspects of this program as a whole and the progress of each Project. This includes assessing the nature of the interactions between Projects and use of the Patient Core A, Cell and Tissue Core B, and Administrative Core C. An important part of these meetings is to find materials or resources that are needed to facilitate collaborations. Other investigators at Mount Sinai and post-doctoral fellows attend the face to face meeting, in order to provide input into novel techniques, approaches and limitations of such endeavors. This keeps the investigators aware of the potential advances of each Project, and aware of new methods available in the Cores. General discussions between all of the members involved in the Program Project Grant foster additional interactions, technically as well as intellectually. Core C organizes a Scientific meeting with the External Advisory Board, which reviews and critiques the project as a whole and advises the Project leaders and the PI as to areas where improvements can be made.
The administrative Core C of this Program Project grant supplies the administrative infrastructure needed to keep the work of investigators, post doctoral fellows, students, participating physicians and nursing staff well coordinated. This Core is in continuous contact with each project to monitor all expenses, review budgets, pay for pertinent materials, organize monthly meetings of Project leaders, organize the Symposium, and arrange visits and meetings with the external Advisory Board.
|Gutzeit, Cindy; Chen, Kang; Cerutti, Andrea (2018) The enigmatic function of IgD: some answers at last. Eur J Immunol 48:1101-1113|
|Gies, Vincent; Schickel, Jean-Nicolas; Jung, Sophie et al. (2018) Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus. JCI Insight 3:|
|Bousfiha, Aziz; Jeddane, Leïla; Picard, Capucine et al. (2018) The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies. J Clin Immunol 38:129-143|
|Nair, Shiny; Sng, Joel; Boddupalli, Chandra Sekhar et al. (2018) Antigen-mediated regulation in monoclonal gammopathies and myeloma. JCI Insight 3:|
|Mayor, Paul C; Eng, Kevin H; Singel, Kelly L et al. (2018) Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry. J Allergy Clin Immunol 141:1028-1035|
|Ho, Hsi-En; Byun, Minji; Cunningham-Rundles, Charlotte (2018) Disseminated Cutaneous Warts in X-Linked Hyper IgM Syndrome. J Clin Immunol 38:454-456|
|Schwab, Charlotte; Gabrysch, Annemarie; Olbrich, Peter et al. (2018) Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects. J Allergy Clin Immunol 142:1932-1946|
|Smith, Tukisa D; Cunningham-Rundles, Charlotte (2018) Detection of anti-glutamic acid decarboxylase antibodies in immunoglobulin products. J Allergy Clin Immunol Pract 6:260-261|
|Petersheim, Daniel; Massaad, Michel J; Lee, Saetbyul et al. (2018) Mechanisms of genotype-phenotype correlation in autosomal dominant anhidrotic ectodermal dysplasia with immune deficiency. J Allergy Clin Immunol 141:1060-1073.e3|
|Bucciol, Giorgia; Moens, Leen; Bosch, Barbara et al. (2018) Lessons learned from the study of human inborn errors of innate immunity. J Allergy Clin Immunol :|
Showing the most recent 10 out of 189 publications